Medical Marijuana, Inc. (OTCPK:MJNA) reported Q2 results and released its OTC disclosure right as the market opened. The stock had gapped up following a huge two-day run (and a promotion by "Money Runners" late in the day on 8/12) but has now reversed, falling below the former key resistance level of $0.20 and declining more than 25% from the prior close. I had recently mentioned some very favorable near-term news, but had warned those considering investment to wait for Q2 results. The report had mostly bad news, but nothing detrimental. I continue to suggest that a better entry should be available in the future.
This is the very high volume price...
Only subscribers can access this article, which is part of the PRO research library covering 3,741 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: